Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo

Yanik M. E., ERFAN G., Albayrak Y., Aydin M., Kulac M., Kuloglu M. M.

NEUROPSYCHIATRIC DISEASE AND TREATMENT, cilt.10, ss.2361-2367, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10
  • Basım Tarihi: 2014
  • Doi Numarası: 10.2147/ndt.s74826
  • Dergi Adı: NEUROPSYCHIATRIC DISEASE AND TREATMENT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2361-2367
  • Anahtar Kelimeler: neurotrophin, psychosomatic, skin, disease, NERVE GROWTH-FACTOR, LIFE QUALITY INDEX, ATOPIC-DERMATITIS PATIENTS, KERATINOCYTE APOPTOSIS, PSYCHIATRIC MORBIDITY, MAJOR DEPRESSION, HUMAN EPIDERMIS, MOOD DISORDERS, HAIR FOLLICLE, SUBSTANCE-P
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Purpose: Vitiligo is an acquired pigmentary skin disease that can cause serious cosmetic problems. There have been numerous and well established studies that have demonstrated the comorbidity of various psychiatric disorders in patients with vitiligo. However, to our knowledge, there have been no studies investigating whether a psychiatric biomarker, such as brain-derived neurotrophic factor (BDNF), is associated with vitiligo.